Market Closed -
Other stock markets
|
Pre-market 09:08:55 am | |||
65.54 USD | +1.17% | 65.62 | +0.13% |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
May. 01 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.10% | 81.73B | |
+31.52% | 690B | |
+25.01% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.89% | 235B | |
+5.42% | 199B | |
-9.94% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences Receives FDA Approval for Updated Label of Biktarvy